Skip to content

Luliconazole

Azole Antifungal — DERMATOLOGICALS

Also known as: lulicon, luzu, NND-502, PR-2699

OnpFDA approvedATC D01AC18

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Luliconazole is an onp drug in the Azole Antifungal class catalogued in DrugCentral. It was first approved by the FDA in 2013. Its mechanism of action is classified as Cytochrome P450 2C19 Inhibitors. DrugCentral lists 1 molecular target, including ERG11. Recorded indications include Tinea corporis, Tinea cruris and Tinea pedis.

  • Approval status: onp (first approved 2013 by the FDA).
  • Drug class: Azole Antifungal.
  • Mechanism of action: Cytochrome P450 2C19 Inhibitors.
  • Molecular targets: ERG11 (1 listed in DrugCentral).
  • Indications: Tinea corporis, Tinea cruris and Tinea pedis.
  • ATC code: D01AC18 (Imidazole and triazole derivatives).
  • Molecular formula: C14H9Cl2N3S2; molecular weight 354.27 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Tinea corporis
  • Tinea cruris
  • Tinea pedis

Mechanism & targets

Mechanism of action (MoA)Cytochrome P450 2C19 Inhibitors
Established pharmacologic classAzole Antifungal

Molecular targets (1)

TargetGeneActionActivity
Lanosterol 14-alpha demethylaseERG11inhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2013-11-14FDA—MEDICIS

ATC classification

ATC codeTherapeutic hierarchy
D01AC18DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Luliconazole is on its molecule page.

Molecular formulaC14H9Cl2N3S2
Molecular weight354.27 g/mol
CAS number187164-19-8
InChIKeyYTAOBBFIOAEMLL-REQDGWNSSA-N
PubChem CID3003141
ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Luliconazole used for?

DrugCentral lists the following indications for Luliconazole: Tinea corporis, Tinea cruris and Tinea pedis.

How does Luliconazole work?

Luliconazole is classified as Cytochrome P450 2C19 Inhibitors; its molecular targets in DrugCentral include ERG11 (inhibitor).

When was Luliconazole first approved?

Luliconazole was first approved by the FDA in 2013.

What drug class does Luliconazole belong to?

Luliconazole is in the Azole Antifungal class.

What is the chemical formula of Luliconazole?

Luliconazole has the molecular formula C14H9Cl2N3S2 and a molecular weight of 354.27 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusONP
First approval2013-11-14
AgencyFDA
Targets1
Indications3
FormulaC14H9Cl2N3S2
DrugCentral ID4813
Interactive profile